Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L3 pseudogene 1 (MRPL3P1) is a processed pseudogene in the human genome that shows homology to the functional MRPL3 gene, which codes for a protein involved in mitochondrial protein synthesis as part of the mitoribosome[6]. Pseudogenes like MRPL3P1 typically do not encode functional proteins, and no evidence is available to suggest this pseudogene is transcribed or has any direct biological or disease-modifying role. The presence of MRPL3P1 does not constitute a therapeutic target, a receptor, or a functionally active molecule for pharmacological intervention[6][4]. In general, some pseudogenes may act as regulatory RNAs via microRNA decoy functions, but this is not specifically established for MRPL3P1[2]. There is nothing to suggest that MRPL3P1 is a misspelled gene symbol or incorrect in nomenclature, but it does not represent a bona fide druggable or functional target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L3 pseudogene 1 (MRPL3P1).